-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Pieris Pharmaceuticals, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2014 to 2023.
- Pieris Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $0.000, a 100% decline year-over-year.
- Pieris Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $19.8 M, a 174% increase from 2022.
- Pieris Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $7.21 M, a 87.8% decline from 2021.
- Pieris Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $59.1 M, a 485% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)